Please assess the completion status of the following clinical trial:

Trial Title: Observational Study of the Heart Repair Technologies Mitral Bridge in Treating Mitral Valve Regurgitation

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients moderate to severe, symptomatic functional (ischemic or dilated cardiomyopathies) mitral regurgitation or mitral regurgitation caused by dilation of the mitral annulus who qualify for mitral valve repair with cardiopulmonary bypass~* Mitral regurgitation must meet the following criteria:~* The primary regurgitant jet is central, originating from mal coaptation of anterior and posterior leaflets of the mitral valve.~* If a secondary jet is present, the jet must be considered clinically insignificant.~* Women of child-bearing potential have a negative pregnancy test~Exclusion Criteria:~* Evidence of severe mitral annular and leaflet calcification.~* Patient is hemodynamically unstable.~* Patient has hypertrophic cardiomyopathy and has systolic anterior motion of the leaflets.~* Patient requires emergency surgery.~* Patient has echocardiographic evidence of endocarditis or rheumatic heart disease.~* Transesophageal Echocardiogram (TEE) is contraindicated or cannot be performed intraoperatively for any reason.~* Patient has known chronic, dialysis-dependent renal failure.~* History of stroke, transient ischemic attack (TIA) or reversible ischemic neurological disease within the last three (3) months.~* History of gastrointestinal bleeding within the last three (3) months.~* History of hypersensitivity or allergy to aspirin~* History or hypersensitivity to clopidogrel (Plavix) or its congeners.~* Active or treated malignancies in the last twelve (12) months.~* Patient is participating in another clinical study for which follow-up is currently ongoing.~* Women of child-bearing age who have not had a negative pregnancy test.~* Patient with non-cardiac co-morbidities and life expectancy \< 1 year.~* Patient has a condition that, in the opinion of the Investigator, precludes participation, including willingness to comply with all follow-up procedures.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).